Position in NVCR
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$4,374,895
+$2,852,165 QoQ
Shares Held
288,772
+106.7% QoQ
Ownership
0.248%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#45
of 217 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVCR Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026Susquehanna Portfolio Strategies, LLC holds $279,523,875 across 30 Medical Devices names. NVCR ranks #13 (1.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MDT |
Medtronic plc
|
957,344 | $74,893,021 | |
| 2 | DXCM |
Dexcom Inc
|
612,127 | $41,226,753 | |
| 3 | GEHC |
GE HealthCare Technologies Inc.
|
548,277 | $35,095,210 | |
| 4 | PEN |
Penumbra Inc
|
66,945 | $21,137,883 | |
| 5 | BRKR |
Bruker Corp
|
348,836 | $20,992,950 | |
| 6 | GMED |
Globus Medical Inc
|
191,945 | $15,165,574 | |
| 7 | GKOS |
GLAUKOS Corp
|
102,507 | $14,326,378 | |
| 8 | LIVN |
LivaNova PLC
|
75,492 | $6,207,707 |
All Filings in NVCR
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,374,895 | 288,772 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $1,522,730 | 139,700 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $3,741,411 | 289,359 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $345,610 | 26,750 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $338,200 | 19,000 | Shares | Sole | 2025-08-14 | |
| No filing history on record for this holder in this stock. | ||||||